Buy Breakdown
Total $0
No buy transactions for this time period.
Sell Breakdown
Total $104,234
Monthly Totals
| Transaction | Filed | Name | Type | Shares @ Price | Value | Balance change | Ownership | |
|---|---|---|---|---|---|---|---|---|
|
12/30/2024
|
12/30/2024 |
Director
|
Sell
|
-3,460 @ $2.46
|
($8,511.60)
|
45,791 | (-7.03%) | Direct |
|
12/16/2024
|
12/18/2024 |
VP, Pharmaceutical Development
Officer
|
Sell
|
-6,300 @ $2.34
|
($14,742.00)
|
14,653 | (-30.07%) | Direct |
|
12/16/2024
|
12/18/2024 |
Head of Regulatory
Officer
|
Sell
|
-2,510 @ $2.34
|
($5,873.40)
|
16,322 | (-13.33%) | Direct |
|
12/16/2024
|
12/18/2024 |
Chief Financial Officer
CFO
|
Sell
|
-2,103 @ $2.34
|
($4,921.02)
|
40,802 | (-4.90%) | Direct |
|
12/16/2024
|
12/18/2024 |
President and CEO
CEO
Director
|
Sell
|
-14,315 @ $2.34
|
($33,497.10)
|
37,372 | (-27.70%) | Direct |
|
06/24/2024
|
07/08/2024 |
Head of Quality
Officer
|
Sell
|
-4,961 @ $2.12
|
($10,517.32)
|
16,174 | (-23.47%) | Direct |
|
06/24/2024
|
07/08/2024 |
General Counsel
Officer
|
Sell
|
-5,496 @ $2.12
|
($11,651.52)
|
19,388 | (-22.09%) | Direct |
|
06/24/2024
|
07/08/2024 |
VP, Clinical Trial Operations
Officer
|
Sell
|
-6,849 @ $2.12
|
($14,519.88)
|
10,869 | (-38.66%) | Direct |